{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T19:43:14Z","timestamp":1692906194064},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00108-023-01571-5","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T16:01:45Z","timestamp":1691510505000},"page":"830-841","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostik der kardialen Amyloidose","Diagnostics of cardiac amyloidosis"],"prefix":"10.1007","volume":"64","author":[{"given":"Claudia","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"issue":"2","key":"1571_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","volume":"2","author":"SF Mohammed","year":"2014","unstructured":"Mohammed\u00a0SF, Mirzoyev\u00a0SA, Edwards\u00a0WD, Dogan\u00a0A, Grogan\u00a0DR, Dunlay\u00a0SM, Roger\u00a0VL, Gertz\u00a0MA, Dispenzieri\u00a0A, Zeldenrust\u00a0SR, Redfield\u00a0MM (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2(2):113\u2013122","journal-title":"JACC Heart Fail"},{"issue":"13","key":"1571_CR2","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi\u00a0C, Merlini\u00a0G, Quarta\u00a0CC, Riva\u00a0L, Longhi\u00a0S, Leone\u00a0O, Salvi\u00a0F, Ciliberti\u00a0P, Pastorelli\u00a0F, Biagini\u00a0E, Coccolo\u00a0F, Cooke\u00a0RM, Bacchi-Reggiani\u00a0L, Sangiorgi\u00a0D, Ferlini\u00a0A, Cavo\u00a0M, Zamagni\u00a0E, Fonte\u00a0ML, Palladini\u00a0G, Salinaro\u00a0F, Musca\u00a0F, Obici\u00a0L, Branzi\u00a0A, Perlini\u00a0S (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120(13):1203\u20131212","journal-title":"Circulation"},{"key":"1571_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.amjcard.2020.05.021","volume":"128","author":"E Donnellan","year":"2020","unstructured":"Donnellan\u00a0E, Wazni\u00a0OM, Saliba\u00a0WI, Hanna\u00a0M, Kanj\u00a0M, Patel\u00a0DR, Wilner\u00a0B, Kochar\u00a0A, Jaber\u00a0WA (2020) Prevalence, incidence, and impact on mortality of conduction system disease in transthyretin cardiac amyloidosis. Am J Cardiol 128:140\u2013146","journal-title":"Am J Cardiol"},{"issue":"1","key":"1571_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00392-020-01661-6","volume":"110","author":"G Chatzantonis","year":"2021","unstructured":"Chatzantonis\u00a0G, Bietenbeck\u00a0M, Florian\u00a0A, Meier\u00a0C, Stalling\u00a0P, Korthals\u00a0D, Reinecke\u00a0H, Yilmaz\u00a0A (2021) Diagnostic value of the novel CMR parameter \u201cmyocardial transit-time\u201d (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy. Clin Res Cardiol 110(1):136\u2013145","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"1571_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","volume":"2","author":"S Dorbala","year":"2014","unstructured":"Dorbala\u00a0S, Vangala\u00a0D, Bruyere\u00a0J Jr., Quarta\u00a0C, Kruger\u00a0J, Padera\u00a0R, Foster\u00a0C, Hanley\u00a0M, Di Carli\u00a0MF, Falk\u00a0R (2014) Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail 2(4):358\u2013367","journal-title":"JACC Heart Fail"},{"issue":"2","key":"1571_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000495455","volume":"141","author":"I Vaxman","year":"2019","unstructured":"Vaxman\u00a0I, Gertz\u00a0M (2019) Recent advances in the diagnosis, risk stratification, and management of systemic light-chain amyloidosis. Acta Haematol 141(2):93\u2013106","journal-title":"Acta Haematol"},{"key":"1571_CR7","doi-asserted-by":"publisher","first-page":"757642","DOI":"10.3389\/fcvm.2021.757642","volume":"8","author":"B Chamling","year":"2021","unstructured":"Chamling\u00a0B, Drakos\u00a0S, Bietenbeck\u00a0M, Klingel\u00a0K, Meier\u00a0C, Yilmaz\u00a0A (2021) Diagnosis of cardiac involvement in amyloid a amyloidosis by cardiovascular magnetic resonance imaging. Front Cardiovasc Med 8:757642","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"1571_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","volume":"55","author":"G Palladini","year":"2009","unstructured":"Palladini\u00a0G, Russo\u00a0P, Bosoni\u00a0T, Verga\u00a0L, Sarais\u00a0G, Lavatelli\u00a0F, Nuvolone\u00a0M, Obici\u00a0L, Casarini\u00a0S, Donadei\u00a0S, Albertini\u00a0R, Righetti\u00a0G, Marini\u00a0M, Graziani\u00a0MS, Melzi D\u2019Eril\u00a0GV, Moratti\u00a0R, Merlini\u00a0G (2009) Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. Clin Chem 55(3):499\u2013504","journal-title":"Clin Chem"},{"issue":"24","key":"1571_CR9","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/eurheartj\/ehad139","volume":"44","author":"MU Rauf","year":"2023","unstructured":"Rauf\u00a0MU, Hawkins\u00a0PN, Cappelli\u00a0F, Perfetto\u00a0F, Zampieri\u00a0M, Argiro\u00a0A, Petrie\u00a0A, Law\u00a0S, Porcari\u00a0A, Razvi\u00a0Y, Bomsztyk\u00a0J, Ravichandran\u00a0S, Ioannou\u00a0A, Patel\u00a0R, Starr\u00a0N, Hutt\u00a0DF, Mahmood\u00a0S, Wisniowski\u00a0B, Martinez-Naharro\u00a0A, Venneri\u00a0L, Whelan\u00a0C, Roczenio\u00a0D, Gilbertson\u00a0J, Lachmann\u00a0HJ, Wechalekar\u00a0AD, Rapezzi\u00a0C, Serenelli\u00a0M, Massa\u00a0P, Caponetti\u00a0AG, Ponziani\u00a0A, Accietto\u00a0A, Giovannetti\u00a0A, Saturi\u00a0G, Sguazzotti\u00a0M, Gagliardi\u00a0C, Biagini\u00a0E, Longhi\u00a0S, Fontana\u00a0M, Gillmore\u00a0JD (2023) Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis. Eur Heart\u00a0J 44(24):2187\u20132198","journal-title":"Eur Heart J"},{"key":"1571_CR10","doi-asserted-by":"publisher","unstructured":"Yilmaz A, Bauersachs J, Bengel F, Buchel R, Kindermann I, Klingel K, Knebel F, Meder B, Morbach C, Nagel E, Schulze-Bahr E, aus dem Siepen\u00a0F, Frey\u00a0N (2021) Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK). Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01799-3","DOI":"10.1007\/s00392-020-01799-3"},{"issue":"30","key":"1571_CR11","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","volume":"39","author":"JD Gillmore","year":"2018","unstructured":"Gillmore\u00a0JD, Damy\u00a0T, Fontana\u00a0M, Hutchinson\u00a0M, Lachmann\u00a0HJ, Martinez-Naharro\u00a0A, Quarta\u00a0CC, Rezk\u00a0T, Whelan\u00a0CJ, Gonzalez-Lopez\u00a0E, Lane\u00a0T, Gilbertson\u00a0JA, Rowczenio\u00a0D, Petrie\u00a0A, Hawkins\u00a0PN (2018) A\u00a0new staging system for cardiac transthyretin amyloidosis. Eur Heart\u00a0J 39(30):2799\u20132806","journal-title":"Eur Heart J"},{"issue":"9","key":"1571_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar\u00a0S, Dispenzieri\u00a0A, Lacy\u00a0MQ, Hayman\u00a0SR, Buadi\u00a0FK, Colby\u00a0C, Laumann\u00a0K, Zeldenrust\u00a0SR, Leung\u00a0N, Dingli\u00a0D, Greipp\u00a0PR, Lust\u00a0JA, Russell\u00a0SJ, Kyle\u00a0RA, Rajkumar\u00a0SV, Gertz\u00a0MA (2012) Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J\u00a0Clin Oncol 30(9):989\u2013995","journal-title":"J Clin Oncol"},{"key":"1571_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jead032","author":"J Abecasis","year":"2023","unstructured":"Abecasis J, Lopes P, Santos RR, Maltes S, Guerreiro S, Ferreira A, Freitas P, Ribeiras R, Andrade MJ, Manso RT, Ramos S, Gil V, Masci PG, Cardim N (2023) Prevalence and significance of relative apical sparing in aortic stenosis: insights from an echo and cardiovascular magnetic resonance study of patients referred for surgical aortic valve replacement. Eur Heart J Cardiovasc Imaging. https:\/\/doi.org\/10.1093\/ehjci\/jead032","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"1571_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi\u00a0C, Quarta\u00a0CC, Guidalotti\u00a0PL, Pettinato\u00a0C, Fanti\u00a0S, Leone\u00a0O, Ferlini\u00a0A, Longhi\u00a0S, Lorenzini\u00a0M, Reggiani\u00a0LB, Gagliardi\u00a0C, Gallo\u00a0P, Villani\u00a0C, Salvi\u00a0F (2011) Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 4(6):659\u2013670","journal-title":"JACC Cardiovasc Imaging"},{"issue":"24","key":"1571_CR15","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore\u00a0JD, Maurer\u00a0MS, Falk\u00a0RH, Merlini\u00a0G, Damy\u00a0T, Dispenzieri\u00a0A, Wechalekar\u00a0AD, Berk\u00a0JL, Quarta\u00a0CC, Grogan\u00a0M, Lachmann\u00a0HJ, Bokhari\u00a0S, Castano\u00a0A, Dorbala\u00a0S, Johnson\u00a0GB, Glaudemans\u00a0AW, Rezk\u00a0T, Fontana\u00a0M, Palladini\u00a0G, Milani\u00a0P, Guidalotti\u00a0PL, Flatman\u00a0K, Lane\u00a0T, Vonberg\u00a0FW, Whelan\u00a0CJ, Moon\u00a0JC, Ruberg\u00a0FL, Miller\u00a0EJ, Hutt\u00a0DF, Hazenberg\u00a0BP, Rapezzi\u00a0C, Hawkins\u00a0PN (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404\u20132412","journal-title":"Circulation"},{"key":"1571_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.02.006","author":"A Martinez-Naharro","year":"2018","unstructured":"Martinez-Naharro A, Kotecha T, Norrington K, Boldrini M, Rezk T, Quarta C, Treibel TA, Whelan CJ, Knight DS, Kellman P, Ruberg FL, Gillmore JD, Moon JC, Hawkins PN, Fontana M (2018) Native T1 and extracellular volume in transthyretin amyloidosis. JACC Cardiovasc Imaging. https:\/\/doi.org\/10.1016\/j.jcmg.2018.02.006","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"1571_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/13506129.2018.1520087","volume":"25","author":"JC Ross","year":"2018","unstructured":"Ross\u00a0JC, Hutt\u00a0DF, Burniston\u00a0M, Page\u00a0J, Steeden\u00a0JA, Gillmore\u00a0JD, Wechalekar\u00a0AD, Hawkins\u00a0PN, Fontana\u00a0M (2018) Quantitation of (99m)Tc-DPD uptake in patients with transthyretin-related cardiac amyloidosis. Amyloid 25(3):203\u2013210","journal-title":"Amyloid"},{"key":"1571_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303765","author":"P Garcia-Pavia","year":"2023","unstructured":"Garcia-Pavia P (2023) Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2303765","journal-title":"Engl J Med"},{"issue":"1","key":"1571_CR19","doi-asserted-by":"publisher","first-page":"15521","DOI":"10.1038\/s41598-021-94650-2","volume":"11","author":"D Korthals","year":"2021","unstructured":"Korthals\u00a0D, Chatzantonis\u00a0G, Bietenbeck\u00a0M, Meier\u00a0C, Stalling\u00a0P, Yilmaz\u00a0A (2021) CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis. Sci Rep 11(1):15521","journal-title":"Sci Rep"},{"key":"1571_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01771-1","author":"G Chatzantonis","year":"2020","unstructured":"Chatzantonis G, Bietenbeck M, Elsanhoury A, Tschope C, Pieske B, Tauscher G, Vietheer J, Shomanova Z, Mahrholdt H, Rolf A, Kelle S, Yilmaz A (2020) Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a\u00a0multi-centre study. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01771-1","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"1571_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2011.04.133","volume":"410","author":"S Bourgault","year":"2011","unstructured":"Bourgault\u00a0S, Choi\u00a0S, Buxbaum\u00a0JN, Kelly\u00a0JW, Price\u00a0JL, Reixach\u00a0N (2011) Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs. Biochem Biophys Res Commun 410(4):707\u2013713","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1571_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore\u00a0JD, Gane\u00a0E, Taubel\u00a0J, Kao\u00a0J, Fontana\u00a0M, Maitland\u00a0ML, Seitzer\u00a0J, O\u2019Connell\u00a0D, Walsh\u00a0KR, Wood\u00a0K, Phillips\u00a0J, Xu\u00a0Y, Amaral\u00a0A, Boyd\u00a0AP, Cehelsky\u00a0JE, McKee\u00a0MD, Schiermeier\u00a0A, Harari\u00a0O, Murphy\u00a0A, Kyratsous\u00a0CA, Zambrowicz\u00a0B, Soltys\u00a0R, Gutstein\u00a0DE, Leonard\u00a0J, Sepp-Lorenzino\u00a0L, Lebwohl\u00a0D (2021) CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N\u00a0Engl J Med 385(6):493\u2013502","journal-title":"N Engl J Med"},{"issue":"11","key":"1571_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson\u00a0MM, Ruberg\u00a0FL, Ambardekar\u00a0AV, Brannagan\u00a0TH, Cheng\u00a0RK, Clarke\u00a0JO, Dember\u00a0LM, Frantz\u00a0JG, Hershberger\u00a0RE, Maurer\u00a0MS, Nativi-Nicolau\u00a0J, Sanchorawala\u00a0V, Sheikh\u00a0FH (2023) ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American college of cardiology solution set oversight committee. J\u00a0Am Coll Cardiol 81(11):1076\u20131126","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1571_CR24","first-page":"523","volume":"75","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M, Gardner\u00a0RS, Baumbach\u00a0A, Bohm\u00a0M, Burri\u00a0H, Butler\u00a0J, Celutkiene\u00a0J, Chioncel\u00a0O, Cleland\u00a0JGF, Coats\u00a0AJS, Crespo-Leiro\u00a0MG, Farmakis\u00a0D, Gilard\u00a0M, Heymans\u00a0S, Hoes\u00a0AW, Jaarsma\u00a0T, Jankowska\u00a0EA, Lainscak\u00a0M, Lam\u00a0CSP, Lyon\u00a0AR, McMurray\u00a0JJV, Mebazaa\u00a0A, Mindham\u00a0R, Muneretto\u00a0C, Piepoli\u00a0MF, Price\u00a0S, Rosano\u00a0GMC, Ruschitzka\u00a0F, Skibelund\u00a0AK (2021) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Rev Esp Cardiol 75(6):523\u20132022","journal-title":"Rev Esp Cardiol"},{"key":"1571_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01799-3","volume-title":"Diagnosis and treatment of cardiac amyloidosis: position statement of the German cardiac society","author":"A Yilmaz","year":"2021","unstructured":"Yilmaz A, Bauersachs J, Bengel F et al (2021) Diagnosis and treatment of cardiac amyloidosis: position statement of the German cardiac society. DGK, Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01799-3"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01571-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:03:15Z","timestamp":1692806595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01571-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1571"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01571-5","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"17 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Yilmaz hat Berater- und Referenten-Honorare von Pfizer, Alnylam, BridgeBio, AstraZeneca und NovoNordisk erhalten. C.\u00a0Meier gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}